
Nasus Pharma presented NS002 data @ ACAAI showing faster time to therapeutic threshold vs epinephrine autoinjector. Under conditions of: *Repeat dosing *Severe nasal congestion ~Allergist survey results also presented on importance of speed ~12-16Nov $NSRX finance.yahoo.com/healthcare…


